Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
暂无分享,去创建一个
Xin Huang | Roberto Pili | R. Figlin | R. Motzer | M. Michaelson | J. Sosman | G. Wilding | Xin Huang | R. Bukowski | C. Szczylik | S. Oudard | P. Tomczak | G. Bjarnason | R. Pili | I. Chen | John A Thompson | Thomas E. Hutson | Jeffrey A Sosman | George Wilding | Robert A Figlin | Cezary Szczylik | Stéphane Oudard | Sylvie Negrier | Thomas E Hutson | Ronald M Bukowski | Isan Chen | Piotr Tomczak | Ewa Solska | S. Négrier | Robert J Motzer | Georg A Bjarnason | M Dror Michaelson | Sindy T Kim | Xavier Garcia-del-Muro | X. Garcia-Del-Muro | Sindy T. Kim | J. Thompson | E. Solska
[1] R. Motzer,et al. Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] C. Porta,et al. Short- and long-term safety with sunitinib in an expanded access trial in metastatic renal cell carcinoma (mRCC) , 2008 .
[3] M. Gordon,et al. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma , 2008 .
[4] R. Motzer,et al. PCN72 HEALTH-RELATED QUALITY OF LIFE (HRQOL)AND KIDNEY CANCER-RELATED SYMPTOMS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)TREATED WITH SUNITINIB VERSUS INTERFERON (IFN)-ALFA IN A RANDOMISED, MULTINATIONAL PHASE III TRIAL: RESULTS FOR EUROPEAN AND US SUBSAMPLE ANALYSES , 2007 .
[5] R. Motzer,et al. Sunitinib efficacy against advanced renal cell carcinoma. , 2007, The Journal of urology.
[6] L. Chow,et al. Sunitinib: from rational design to clinical efficacy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] R. Figlin,et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. , 2007, The New England journal of medicine.
[8] B. Rini,et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. , 2007, Journal of the National Cancer Institute.
[9] J. Desai,et al. Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors , 2006, Annals of Internal Medicine.
[10] M. Blute. Sunitinib in patients with metastatic renal cell carcinoma , 2006 .
[11] R. Motzer,et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. Christian,et al. [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.
[13] W. D. Ray. 4. Modelling Survival Data in Medical Research , 1995 .
[14] David Collett. Modelling Survival Data in Medical Research , 1994 .